✦ LIBER ✦

P-531 Phase II study of sequential gemcitabine (G) and carboplatin (C) followed by docetaxel (D) as first line chemotherapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Chiappori, Alberto; Simon, George; Lima, Caio Rocha; Williams, Charles; Haura, Eric; Vaughn, Jeannie; Cantor, Alan; Wagner, Henry; Bepler, Gerold; Antonia, Scott

Book ID: 118572227
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 360 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92498-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of sequential docetaxel

A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB

A phase II study of Gemcitabine (G) plus

A phase II study of Gemcitabine (G) plus Docetaxel (D) as first line chemotherapy for advanced NSCLC patients (PTS)

✍ Ventriglia, M; Estevez, R; Cabrera, L; Spector, C; Álvarez, A.A; Cilurzo, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

1307 POSTER First-line chemotherapy with

1307 POSTER First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study

✍ C. Tibaldi; E. Vasile; M. Lo Dico; A. Antonuzzo; R. Di Marsico; G. Tartarelli; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Sequential chemotherapy with carboplatin

Sequential chemotherapy with carboplatin (C) and gemcitabine (G) followed by paclitaxel (P) in poor performance status (PS) and elderly patients (pts) with non-small cell lung cancer (NSCLC)

✍ Edelman, M.J; Gandara, D.R; Lau, D; Lara, P; Lauder, I 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Phase II study of docetaxel (DOC) and ca

Phase II study of docetaxel (DOC) and carboplatin (CP) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A phase I–II study of docetaxel (D) and

A phase I–II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC)

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB